procainamide has been researched along with Bright Disease in 5 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 61-year-old man developed clinical lupus syndrome with positive antinuclear antibody, positive lupus erythematosus (LE) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of procainamide therapy." | 8.76 | Glomerulonephritis in procainamide induced lupus erythematosus: report of a case and review of the literature. ( Erickson, DG; Foucar, E; Tung, KS, 1979) |
| "A 61-year-old man developed clinical lupus syndrome with positive antinuclear antibody, positive lupus erythematosus (LE) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of procainamide therapy." | 4.76 | Glomerulonephritis in procainamide induced lupus erythematosus: report of a case and review of the literature. ( Erickson, DG; Foucar, E; Tung, KS, 1979) |
| "Renal failure secondary to crescentic glomerulonephritis developed in a patient who had typical serologic features of drug-induced systemic lupus erythematosus after two years of therapy with procainamide." | 3.66 | Renal manifestations of drug-induced systemic lupus erythematosus. ( Charron, RC; Katz, A; Sheikh, TK, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheikh, TK | 1 |
| Charron, RC | 1 |
| Katz, A | 1 |
| Foucar, E | 1 |
| Erickson, DG | 1 |
| Tung, KS | 1 |
| Nguyen, KP | 1 |
| Thomsen, G | 1 |
| Liem, B | 1 |
| Swerdlow, CD | 1 |
| Franz, MR | 1 |
| Lambert, PH | 1 |
| Creighton, D | 1 |
| Goodman, R | 1 |
| Bankhurst, A | 1 |
| Mischer, PA | 1 |
1 review available for procainamide and Bright Disease
| Article | Year |
|---|---|
Glomerulonephritis in procainamide induced lupus erythematosus: report of a case and review of the literature.
Topics: Azathioprine; Biopsy; Glomerulonephritis; Humans; Kidney Glomerulus; Lupus Erythematosus, Systemic; | 1979 |
4 other studies available for procainamide and Bright Disease
| Article | Year |
|---|---|
Renal manifestations of drug-induced systemic lupus erythematosus.
Topics: Biopsy; Fluorescent Antibody Technique; Glomerulonephritis; Humans; Kidney; Lupus Erythematosus, Sys | 1981 |
N-acetylprocainamide, torsades de pointes, and hemodialysis.
Topics: Acecainide; Adult; Female; Glomerulonephritis; Humans; Procainamide; Renal Dialysis; Tachycardia | 1986 |
[Experimental approach to the pathogenesis of systemic lupus erythematosus].
Topics: Animals; Antigen-Antibody Complex; Autoantibodies; Cyclophosphamide; Disease Models, Animal; DNA; Fe | 1972 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 21-1968.
Topics: Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Glomerulonephritis; Granuloma; Humans; Lung | 1968 |